Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma Metastatic in the Brain|Estrogen Receptor Negative|HER2/Neu Negative|HER2/Neu Positive|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IV Breast Cancer
Interventions: PROCEDURE: Cognitive Assessment|DRUG: Palbociclib|PROCEDURE: Quality-of-Life Assessment|BIOLOGICAL: Trastuzumab
Sponsor: Northwestern University
Collaborators: Pfizer|National Cancer Institute (NCI)